Eleanor Brooks
banner
eleanorbrooks.bsky.social
Eleanor Brooks
@eleanorbrooks.bsky.social
Senior Lecturer in European Health Policy at University of Edinburgh. Research on regulatory management, impact assessment, Better Regulation, fiscal governance, and the intersection of the above with (EU) health policy.
Reposted by Eleanor Brooks
“DG SANTE’s continued pressure on health CSOs sends a worrying message. As the US experience shows, government–civil society partnerships are easy to break—restoring the value that they bring to policymaking is much harder.” @eleanorbrooks.bsky.social @hjarman.bsky.social @eupha.bsky.social
EURO-DOGE by stealth? Concerning developments in the (de)funding of European health civil society
At the time of writing in June 2025, the European Commission’s directorate general for health, DG SANTE, has yet to publish its work programme for the year
academic.oup.com
July 29, 2025 at 4:56 PM
Reposted by Eleanor Brooks
New article in @bmj Global Health with Emily Adrion and Jeff Collin: "Who funds the WHO Foundation? A
transparency analysis of donation disclosures over the first 3 years of its operation" gh.bmj.com/content/10/7... @lhgp.bsky.social @uoe-sps.bsky.social
Who funds the WHO Foundation? A transparency analysis of donation disclosures over the first 3 years of its operation
Introduction The WHO Foundation (WHOF) was established in 2020 with the stated aim of broadening the donor pool to the WHO. Academics and civil society actors raised concerns regarding the potential n...
gh.bmj.com
July 24, 2025 at 6:48 AM
Reposted by Eleanor Brooks
@jacktaggart.bsky.social and I have been working together on multistakeholderism, and thinking about how these hybrid forms of governance connect to multilateralism

This is an attempt to think through institutional hybridity in global plastics governance

www.globalpolicyjournal.com/articles/glo...
Early View Article - The Trojan Horse of Hybrid Governance: Corporate Power and Global Plastics Governance | Global Policy Journal
This article examines the emergence of a hybrid institutional complex (HIC) in global plastics governance. By interrogating the structure, features, and contradictions of hybrid global plastics govern...
www.globalpolicyjournal.com
July 17, 2025 at 11:13 AM
Reposted by Eleanor Brooks
Remember Piepergate? The EU Commission officially ended today the position of EU SME Envoy, which was vacant since the resignation of Markus Pieper one year ago
(below the new organisation chart of DG Grow, without the position)
www.mlex.com/mlex/energy/...
May 1, 2025 at 8:13 AM
Reposted by Eleanor Brooks
EPHA and the University of Edinburgh have developed a series of explainers on the Better Regulation agenda.

Find this and all resources on our dedicated page: epha.org/brbh-toolkit/

@eleanorbrooks.bsky.social @clemricherdel.bsky.social @ukri.org
April 24, 2025 at 7:02 AM
Reposted by Eleanor Brooks
𝐂𝐨𝐦𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭 𝐯𝐨𝐧 𝐝𝐞𝐫 𝐋𝐞𝐲𝐞𝐧'𝐬 𝐜𝐚𝐦𝐩𝐚𝐢𝐠𝐧 𝐨𝐧 𝐝𝐞𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 ➡️ 𝐖𝐞 𝐫𝐢𝐬𝐤 𝐚 𝐝𝐢𝐬𝐚𝐬𝐭𝐫𝐨𝐮𝐬 𝐡𝐚𝐥𝐟-𝐝𝐞𝐜𝐚𝐝𝐞 𝐨𝐟 𝐝𝐞𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧, 𝐰𝐡𝐢𝐥𝐞 𝐜𝐥𝐢𝐦𝐚𝐭𝐞 𝐜𝐡𝐚𝐧𝐠𝐞 🌏 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭 🌳💧 𝐞𝐪𝐮𝐚𝐥𝐢𝐭𝐲 👥 & 𝐬𝐨𝐜𝐢𝐚𝐥 𝐫𝐢𝐠𝐡𝐭𝐬 ✊ 𝐚𝐫𝐞 𝐩𝐮𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐛𝐚𝐜𝐤𝐛𝐮𝐫𝐧𝐞𝐫 – 𝐚𝐥𝐥 𝐢𝐧 𝐭𝐡𝐞 𝐧𝐚𝐦𝐞 𝐨𝐟 ‘𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬’.

✒ by Olivier Hoedeman @corporateeurope.bsky.social
Why Progressives Must Organise to Stop the EU’s Deregulation Wave
Under von der Leyen’s lead, the European Commission is driving a far-reaching deregulatory agenda, threatening social and environmental protections. Olivier Hoedeman (Corporate Europe Observatory) rev...
transform-network.net
April 14, 2025 at 9:51 AM
Reposted by Eleanor Brooks
LAUNCH: Today, we publish a toolkit for civil society, to support engagement with the Better Regulation agenda! You can find:

🔸Videos
🔸Explainers
🔸How Better Regulation processes affect health
and much more!

Access the toolkit now: lnkd.in/edKwMpGm
April 14, 2025 at 12:46 PM
Reposted by Eleanor Brooks
#Earlyview #Openaccess

'Impact Assessment as Agenda-Setting: Procedural Politicking and the Mobilization of Bias in the European Union's Audiovisual Media Services Directive'
By @eleanorbrooks.bsky.social & @kat-lauber.bsky.social

#RegGov #BetterRegulation

onlinelibrary.wiley.com/doi/full/10....
March 14, 2025 at 9:55 PM
Reposted by Eleanor Brooks
Clean Industrial Deal risks becoming yet another example of corporate capture.

Without strong transparency rules & enforcement, plus real accountability, industry will continue to write the EU’s agenda behind closed doors.

✊ We need #lobbyingfirewall to protect public interest decision-making!
February 24, 2025 at 7:20 AM
Reposted by Eleanor Brooks
Big business spends millions lobbying the EU, but who are the top spenders, and what do they want?

Together with @lobbycontrol.bsky.social we took a look and can reveal that declared corporate lobby spend has reached unprecedented levels.

#lobbying
#lobbyingfirewall
#corporatecapture
February 24, 2025 at 7:20 AM
Reposted by Eleanor Brooks
new paper with @jacktaggart.bsky.social in @gepjournal.bsky.social on corporate power, multistakeholderism and the Global Plastics Treaty

we contend that multistakeholder partnerships constitute a key hedging strategy for companies facing regulatory pressures to address plastics pollution
Plastic Partnerships: How Corporations Are Hedging Against the UN Global Plastics Treaty
Abstract. The global plastic crisis has intensified over the past decade, pressuring corporations to address their environmental impact. In response to a UN resolution to negotiate a treaty to end pla...
direct.mit.edu
February 24, 2025 at 9:05 AM
Reposted by Eleanor Brooks
2024 marked 70 years since the tobacco industry, faced with mounting evidence of the harm caused by its products, issued their “Frank Statement” to smokers reassuring them that the link between smoking and lung cancer was yet to be proven.🧵
February 13, 2025 at 12:22 PM
Planned European Commission Recommendation on reducing #health / #cancer risk associated with sunbeds withdrawn yesterday ec.europa.eu/info/law/bet...
European Commission - Have your say
European Commission - Have your say
ec.europa.eu
February 5, 2025 at 8:11 AM
Strange developments re the EU's new #CriticalMedicinesAct. Widely considered the most important piece of health-related legislation announced for this mandate, but to have no impact assessment or genuine* public consultation, on the basis of its 'urgency'... 1/9
In a "cynical move", the EU executive is pushing ahead with an extremely streamlined timeline for a key piece of health legislation, making it clear that it will likely be finalised well before the consultation period with stakeholders ends. With @martairaola.bsky.social for @euronews.com
Commission cuts feedback amid races to push Critical Medicines Act
The EU executive is expected to push ahead with an extremely streamlined timeline for a key piece of health legislation, aiming to present it within the first 100 days of the new administration.
www.euronews.com
February 2, 2025 at 2:15 PM
Reposted by Eleanor Brooks
given that the USAID website has just gone offline, I feel it is profoundly misguided for public health experts to be giving this administration any credit whatsoever
February 1, 2025 at 10:38 PM
Reposted by Eleanor Brooks
Todays biggest story, I think. CEOs Vicky Cann has written a great report on industry lobbying in the EU against a universal PFAS ban. They are good at it - the lobbyists for the PFAS producers, the chem. industry, pharma industry and others. There's a risk very little will be done in coming years.
#PFAS, or forever chemicals, are widespread.

Check out our new report which shows how EU’s proposed PFAS restriction is at serious risk of being hijacked by corporate lobbying.

Read it here and sign the petition for a #ToxicFreeEurope 👉 corporateeurope.org/en/chemical-...
January 14, 2025 at 8:57 AM
⏳ One week left to submit an abstract for our upcoming workshop on politics and health care/policy - deadline 21 Nov - feel free to get in touch with any questions. Full details below 👇
November 14, 2024 at 3:36 PM
Fab opportunity to spend four days discussing all things political science and health - come join us in Prague in May 2025 - deadline for applications = 21 November. Full details and call for papers at www.linkedin.com/feed/update/...
Eleanor Brooks on LinkedIn: Towards a political science of health and healthcare
Call for papers - Towards a political science of health and healthcare ECPR Joint Sessions workshop, Charles University Prague 20-23 May 2025 We are delighted…
www.linkedin.com
October 24, 2024 at 2:55 PM
This is a major challenge facing health - as well as social, environmental and labour - policy at EU level, and a key opportunity to work together to change the narrative on regulation 👇 #betterregulation
For decades, the European Union loved to regulate. Now, it wants to do the opposite.

🔗 www.politico.eu/article/eu-r...
September 25, 2024 at 1:16 PM
Reposted by Eleanor Brooks
Yesterday the EU Ombudsman responded to our complaint about 🇪🇺 Commission’s Regulatory Scrutiny Board (RSB), its contacts with lobbyists, & whether it really has the full range of policy expertise needed for such an influential role.
Original complaint ⤵️
corporateeurope.org/en/2023/03/e...
European Ombudsman announces new inquiry into Regulatory Scrutiny Board
The European Ombudsman has responded positively to our request for an inquiry into the role of the Commission's Regulatory Scrutiny Board.
corporateeurope.org
September 18, 2024 at 9:20 AM
Reposted by Eleanor Brooks
Worst fears confirmed with #draghireport on the next years priorities in the EU. What von der Leyen left vague is concretised.

Key proposals will lead to a tighter corporate stranglehold over EU rules.

🧵Here are 4 examples:👇
September 9, 2024 at 2:18 PM
Reposted by Eleanor Brooks
European health policy starter pack

My favourite European health policy and law connections on Bluesky so far

go.bsky.app/K2JB6CN
August 26, 2024 at 8:29 AM
Reposted by Eleanor Brooks
new paper in BMJ Global Health on conceptualising the 'commercial determinants of health' with the brilliant Ellie Brooks and Charlotte Godziewski

We highlight a tendency to overlook the importance of political institutions in shaping the exercise of corporate power

gh.bmj.com/content/8/11...
November 28, 2023 at 9:46 AM